Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 38621200

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2024 Jun 25
First author
van Weelderen RE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      van Weelderen RE
      type
      Author
    2. name
      Harrison CJ
      type
      Author
    3. name
      Klein K
      type
      Author
    4. name
      Jiang Y
      type
      Author
    5. name
      Abrahamsson J
      type
      Author
    6. name
      Alonzo T
      type
      Author
    7. name
      Aplenc R
      type
      Author
    8. name
      Arad-Cohen N
      type
      Author
    9. name
      Bart-Delabesse E
      type
      Author
    10. name
      Buldini B
      type
      Author
    11. name
      De Moerloose B
      type
      Author
    12. name
      Dworzak MN
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      van Weelderen RE
      type
      Author
    2. name
      Harrison CJ
      type
      Author
    3. name
      Klein K
      type
      Author
    4. name
      Jiang Y
      type
      Author
    5. name
      Abrahamsson J
      type
      Author
    6. name
      Alonzo T
      type
      Author
    7. name
      Aplenc R
      type
      Author
    8. name
      Arad-Cohen N
      type
      Author
    9. name
      Bart-Delabesse E
      type
      Author
    10. name
      Buldini B
      type
      Author
    11. name
      De Moerloose B
      type
      Author
    12. name
      Dworzak MN
      type
      Author
    bibliography ids
    1. nci-bib-00cff7597b95b20fe895e4f2
    book metadata
    content sha256
    17841b28d59637fa19c840c1345a9bd02148e66939ea727491098bb0a08849e5
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2023011771
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38621200
    immutable id
    pubmed:38621200@17841b28d59637fa19c840c1345a9bd02148e66939ea727491098bb0a08849e5
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    12
    name
    Blood advances
    nlm unique id
    101698425
    pages
    3200-3213
    volume
    8
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38621200
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      83bf386022a7fd4737eea5916a48368113e58af5402e4a0049a8ed937e247dad
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Jun 25
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38621200/
      title
      Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

      Preserved source evidence · Independent clinical review pending · Not medical advice